Annual SGA
$8.02 M
-$2.58 M-24.35%
December 1, 2023
Summary
- As of February 7, 2025, ADXN annual SGA is $8.02 million, with the most recent change of -$2.58 million (-24.35%) on December 1, 2023.
- During the last 3 years, ADXN annual SGA has risen by +$1.89 million (+30.84%).
- ADXN annual SGA is now -59.48% below its all-time high of $19.80 million, reached on December 31, 2011.
Performance
ADXN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$390.00 K
-$170.80 K-30.46%
September 1, 2024
Summary
- As of February 7, 2025, ADXN quarterly SGA is $390.00 thousand, with the most recent change of -$170.80 thousand (-30.46%) on September 1, 2024.
- Over the past year, ADXN quarterly SGA has dropped by -$146.70 thousand (-27.33%).
- ADXN quarterly SGA is now -93.86% below its all-time high of $6.36 million, reached on December 1, 2023.
Performance
ADXN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.64 B
-$27.79 M-1.72%
September 1, 2024
Summary
- As of February 7, 2025, ADXN TTM SGA is -$1.64 billion, with the most recent change of -$27.79 million (-1.72%) on September 1, 2024.
- Over the past year, ADXN TTM SGA has dropped by -$1.65 billion (-37233.15%).
- ADXN TTM SGA is now -934.16% below its all-time high of -$158.64 million.
Performance
ADXN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ADXN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.4% | -27.3% | -10000.0% |
| 3 y3 years | +30.8% | -79.9% | -10000.0% |
| 5 y5 years | +181.2% | -78.3% | -10000.0% |
ADXN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.4% | at low | -93.9% | at low | -17.9% | at low |
| 5 y | 5-year | -24.4% | +85.0% | -93.9% | +151.1% | -168.5% | at low |
| alltime | all time | -59.5% | +858.1% | -93.9% | +151.1% | -934.2% | at low |
Addex Therapeutics Ltd Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $390.00 K(-30.5%) | $7.96 M(-1.8%) |
| Jun 2024 | - | $560.80 K(-14.3%) | $8.11 M(-1.2%) |
| Mar 2024 | - | $654.20 K(-89.7%) | $8.21 M(+1.3%) |
| Dec 2023 | $8.02 M(-24.4%) | $6.36 M(+1084.3%) | $8.10 M(+83.3%) |
| Sep 2023 | - | $536.70 K(-18.7%) | $4.42 M(-30.5%) |
| Jun 2023 | - | $659.80 K(+21.1%) | $6.36 M(-19.3%) |
| Mar 2023 | - | $545.00 K(-79.6%) | $7.87 M(-25.9%) |
| Dec 2022 | $10.61 M(+25.1%) | $2.68 M(+8.2%) | $10.63 M(+7.4%) |
| Sep 2022 | - | $2.47 M(+13.6%) | $9.89 M(+2.5%) |
| Jun 2022 | - | $2.18 M(-34.0%) | $9.66 M(+1.6%) |
| Mar 2022 | - | $3.30 M(+70.1%) | $9.50 M(+24.0%) |
| Dec 2021 | $8.48 M(+38.2%) | $1.94 M(-13.3%) | $7.67 M(+30.7%) |
| Sep 2021 | - | $2.24 M(+10.3%) | $5.86 M(+7.8%) |
| Jun 2021 | - | $2.03 M(+38.7%) | $5.44 M(+7.5%) |
| Mar 2021 | - | $1.46 M(+966.4%) | $5.06 M(-5.0%) |
| Dec 2020 | $6.13 M | $137.10 K(-92.4%) | $5.33 M(+20.3%) |
| Sep 2020 | - | $1.81 M(+10.2%) | $4.43 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $1.65 M(-4.7%) | $4.41 M(+4.1%) |
| Mar 2020 | - | $1.73 M(-326.5%) | $4.23 M(+5.6%) |
| Dec 2019 | $4.34 M(+52.0%) | -$763.00 K(-142.6%) | $4.01 M(-16.0%) |
| Sep 2019 | - | $1.79 M(+21.6%) | $4.77 M(+60.2%) |
| Jun 2019 | - | $1.47 M(-2.0%) | $2.98 M(+98.0%) |
| Mar 2019 | - | $1.50 M | $1.50 M |
| Dec 2018 | $2.85 M(+240.7%) | - | - |
| Dec 2017 | $837.50 K(-45.8%) | - | - |
| Dec 2016 | $1.55 M(-5.1%) | - | - |
| Dec 2015 | $1.63 M(-3.8%) | - | - |
| Dec 2014 | $1.69 M(-79.7%) | - | - |
| Dec 2013 | $8.35 M(-37.1%) | - | - |
| Dec 2012 | $13.27 M(-33.0%) | - | - |
| Dec 2011 | $19.80 M(+222.2%) | - | - |
| Dec 2010 | $6.14 M(-12.4%) | - | - |
| Dec 2009 | $7.02 M(+0.3%) | - | - |
| Dec 2008 | $6.99 M(-22.1%) | - | - |
| Dec 2007 | $8.98 M | - | - |
FAQ
- What is Addex Therapeutics Ltd annual SGA?
- What is the all time high annual SGA for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd annual SGA year-on-year change?
- What is Addex Therapeutics Ltd quarterly SGA?
- What is the all time high quarterly SGA for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly SGA year-on-year change?
- What is Addex Therapeutics Ltd TTM SGA?
- What is the all time high TTM SGA for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd TTM SGA year-on-year change?
What is Addex Therapeutics Ltd annual SGA?
The current annual SGA of ADXN is $8.02 M
What is the all time high annual SGA for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual SGA is $19.80 M
What is Addex Therapeutics Ltd annual SGA year-on-year change?
Over the past year, ADXN annual SGA has changed by -$2.58 M (-24.35%)
What is Addex Therapeutics Ltd quarterly SGA?
The current quarterly SGA of ADXN is $390.00 K
What is the all time high quarterly SGA for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly SGA is $6.36 M
What is Addex Therapeutics Ltd quarterly SGA year-on-year change?
Over the past year, ADXN quarterly SGA has changed by -$146.70 K (-27.33%)
What is Addex Therapeutics Ltd TTM SGA?
The current TTM SGA of ADXN is -$1.64 B
What is the all time high TTM SGA for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high TTM SGA is -$158.64 M
What is Addex Therapeutics Ltd TTM SGA year-on-year change?
Over the past year, ADXN TTM SGA has changed by -$1.65 B (-37233.15%)